Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 19, 2019
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
[ Thu, Dec 19th 2019
] - WOPRAI
Wed, December 18, 2019
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
[ Wed, Dec 18th 2019
] - WOPRAI
Zegbeh Jallah Initiated (XFOR) at Strong Buy and Held Target at $20 on, Dec 18th, 2019
Zegbeh Jallah of Roth Capital, Initiated "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy and Held Target at $20 on, Dec 18th, 2019.
Zegbeh has made no other calls on XFOR in the last 4 months.
There are 2 other peers that have a rating on XFOR. Out of the 2 peers that are also analyzing XFOR, 0 agree with Zegbeh's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Zegbeh
- Joel Beatty of "Citigroup" Upgraded from Hold to Strong Buy on, Monday, December 9th, 2019
- Mayank Mamtani of "B. Riley Securities" Initiated at Strong Buy and Held Target at $25 on, Thursday, December 5th, 2019
